New NMOSD Resource Pack puts Treatment Information at your Fingertips
Treatment options for NMOSD continue to grow. In addition to the already existing off-label therapies, the FDA has approved the medications Soliris, Uplizna, and Enspryng for use in treating NMOSD.
In order to keep you informed, we at SRNA have developed additional online resources that cover the latest advancements in NMOSD care and therapeutics.
Our brand-new SRNA NMOSD resource pack includes:
- An “NMOSD Therapeutics at a Glance Tool” that offers comprehensive answers to frequently asked questions about all three FDA-approved drugs and the three off-label medications that are widely used. We have included information on side effects, trial results and efficacy, safety profiles, the mechanism of action, mode of therapeutic intervention, and more.
- An “NMOSD Medications Page” for a targeted view of dedicated information about the specific drugs below:
- An updated NMOSD information sheet that includes information about the three FDA-approved drugs.
We hope these resources will help you learn more about all NMOSD therapies, improve your quality of life, and better advocate for your care. Please reach out to us if you have any questions!
